IP Library › Granted Patent US 11,541,054
Granted Patent B2
US 11,541,054 · App. 17/834,268 · Granted Jan 3, 2023

Methods and compositions for the treatment of hair loss

Inventor: John Edward Wurst (Poway, CA)
Assignee: Aneira Pharma, Inc.
A61K31/506A61K9/0014A61K31/222A61K31/25A61K31/5575A61K31/58A61K38/13A61K47/10A61K47/12A61K47/26A61P17/14
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,541,054
App. No.
17/834,268
Granted
Jan 3, 2023
Kind
B2
Abstract

Compositions and methods for the treatment of hair growth and the prevention of hair loss.

Claims (20)

1. A pharmaceutical composition for use in growing hair wherein the composition's active agents consist of latanoprost and minoxidil.

2. The pharmaceutical composition of claim 1 wherein the pharmaceutical composition grows hair in patients suffering from hair loss disorders.

3. The pharmaceutical composition of claim 1 wherein the pharmaceutical composition grows hair in patients suffering from androgenetic alopecia.

4. The pharmaceutical composition of claim 1 wherein the pharmaceutical composition further comprises one selected from the group consisting of polysorbate 60, oleyl alcohol and benzyl alcohol.

5. The pharmaceutical composition of claim 1 wherein the pharmaceutical composition further comprises one selected from the group consisting of polyethylene lauryl alcohol, diethethylene glycol monoethyl ether and polyethylene glycol.

6. The pharmaceutical composition of claim 1 wherein the pharmaceutical composition comprises 30%-60% w/v propylene glycol.

7. The pharmaceutical composition of claim 6 wherein the pharmaceutical composition comprises 10%-20% w/v propanediol.

8. The pharmaceutical composition of claim 6 wherein the pharmaceutical composition comprises 20%-40% w/v ethanol.

9. The pharmaceutical composition of claim 6 wherein the pharmaceutical composition comprises 0.1%-10% w/v diethylene glycol monoethyl ether.

10. The pharmaceutical composition of claim 6 wherein the pharmaceutical composition comprises 0.1%-3% w/v oleyl alcohol.

11. A pharmaceutical composition for use in growing hair wherein the composition's active agents consist of latanoprost and minoxidil and further comprising propylene glycol.

12. The pharmaceutical composition of claim 11 further comprising water.

13. The pharmaceutical composition of claim 11 further comprising propanediol.

14. The pharmaceutical composition of claim 11 further comprising ethanol.

15. The pharmaceutical composition of claim 11 wherein the composition comprises 0.01-0.10% w/v latanoprost and 10-60% w/v propylene glycol.

16. The pharmaceutical composition of claim 11 wherein the composition comprises 0.01-0.08% w/v latanoprost and 10-60% w/v propylene glycol.

17. The pharmaceutical composition of claim 11 wherein the composition comprises 1-6% w/v minoxidil and 10-60% w/v propylene glycol.

18. A pharmaceutical composition for use in growing hair wherein the composition's active agents consist of latanoprost and minoxidil and further comprising diethylene glycol monoethyl ether.

19. The pharmaceutical composition according to claim 18 further comprising one selected from the group consisting of polyethylene lauryl alcohol and polyethylene glycol.

20. The pharmaceutical composition according to claim 18 further comprising oleyl alcohol.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 7, 2022
From: WURST, JOHN EDWARD
To: ANEIRA PHARMA, INC.
Reel/Frame 060123/0440 →
Continuity (7)
Continuation 17501130 · Oct 14, 2021
Continuation 17233507 · Apr 18, 2021
Continuation 16983740 · Aug 3, 2020
Provisional Application 63100611 · Mar 23, 2020
Provisional Application 62895869 · Sep 4, 2019
Provisional Application 62883809 · Aug 7, 2019
Related Publication 20220296596A1 · Sep 22, 2022